Literature DB >> 4006720

Adverse effects secondary to baclofen withdrawal.

S M Garabedian-Ruffalo, R L Ruffalo.   

Abstract

Drug therapy is now the preferred method of treatment for spasticity, and several effective agents have been developed. The safety and efficacy of these drugs has been established in short-term studies. Overall, due to its low incidence of sedation and serious side effects, baclofen appears to be the drug of choice in the treatment of spinal cord-related spasticity. It is, however, not without its side effects due to both its administration and abrupt withdrawal. This case illustrates some significant problems associated with the abrupt withdrawal of long-term baclofen therapy in a patient with multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006720     DOI: 10.1177/106002808501900415

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  5 in total

1.  Intrathecal baclofen withdrawal syndrome following posterior spinal fusion for neuromuscular scoliosis: a case report.

Authors:  Pedro Fernandes; Lori Dolan; Stuart L Weinstein
Journal:  Iowa Orthop J       Date:  2008

Review 2.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

Review 3.  A benefit-risk assessment of baclofen in severe spinal spasticity.

Authors:  Alessandro Dario; Giustino Tomei
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

4.  Pharmacokinetics of baclofen in spastic patients receiving multiple oral doses.

Authors:  E W Wuis; M J Dirks; T B Vree; E Van der Kleijn
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

Review 5.  Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.

Authors:  Paulina Cieślik; Joanna M Wierońska
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.